"then it was all about the tissue science, never mind the approved product that was superior but somehow they couldn't sell despite recruiting sales people all over north America then to turn around and need to sack them."
I attended an AGM at that time when Lee Rodne was CEO. I asked how could a low priced product sold in small quantities support a dedicated sales force. His response was that we needed a dedicated sales force because the products technical qualities needed to be explained. All tommy rot in my view.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-32
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.15 |
Change
0.350(2.97%) |
Mkt cap ! $256.8M | |||
| Open | High | Low | Value | Volume |
| $11.80 | $12.15 | $11.21 | $376.0K | 32.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 139 | $12.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 830 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |